Viridian Therapeutics, Inc.

Q4 2025 13F Holders

Symbol
VRDN
CUSIP
92790C104
Type
Equity
Class
COM
Num filings
237
Total reported value, excl. options
$3.36 B
Manager Report Date Value ($000) Shares Option Type